Cargando…

Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure

INTRODUCTION: Despite having higher sensitivity as compared to conventional troponins, sensitive troponins have lower specificity, mainly in patients with renal failure. OBJECTIVE: Study aimed at assessing the sensitive troponin I levels in patients with chest pain, and relating them to the existenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Soeiro, Alexandre de Matos, Gualandro, Danielle Menosi, Bossa, Aline Siqueira, Zullino, Cindel Nogueira, Biselli, Bruno, Soeiro, Maria Carolina Feres de Almeida, Leal, Tatiana de Carvalho Andreucci Torres, Serrano Jr., Carlos Vicente, de Oliveira Junior, Mucio Tavares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831304/
https://www.ncbi.nlm.nih.gov/pubmed/29538525
http://dx.doi.org/10.5935/abc.20170182
_version_ 1783303146958749696
author Soeiro, Alexandre de Matos
Gualandro, Danielle Menosi
Bossa, Aline Siqueira
Zullino, Cindel Nogueira
Biselli, Bruno
Soeiro, Maria Carolina Feres de Almeida
Leal, Tatiana de Carvalho Andreucci Torres
Serrano Jr., Carlos Vicente
de Oliveira Junior, Mucio Tavares
author_facet Soeiro, Alexandre de Matos
Gualandro, Danielle Menosi
Bossa, Aline Siqueira
Zullino, Cindel Nogueira
Biselli, Bruno
Soeiro, Maria Carolina Feres de Almeida
Leal, Tatiana de Carvalho Andreucci Torres
Serrano Jr., Carlos Vicente
de Oliveira Junior, Mucio Tavares
author_sort Soeiro, Alexandre de Matos
collection PubMed
description INTRODUCTION: Despite having higher sensitivity as compared to conventional troponins, sensitive troponins have lower specificity, mainly in patients with renal failure. OBJECTIVE: Study aimed at assessing the sensitive troponin I levels in patients with chest pain, and relating them to the existence of significant coronary lesions. METHODS: Retrospective, single-center, observational. This study included 991 patients divided into two groups: with (N = 681) and without (N = 310) significant coronary lesion. For posterior analysis, the patients were divided into two other groups: with (N = 184) and without (N = 807) chronic renal failure. The commercial ADVIA Centaur(®) TnI-Ultra assay (Siemens Healthcare Diagnostics) was used. The ROC curve analysis was performed to identify the sensitivity and specificity of the best cutoff point of troponin as a discriminator of the probability of significant coronary lesion. The associations were considered significant when p < 0.05. RESULTS: The median age was 63 years, and 52% of the patients were of the male sex. The area under the ROC curve between the troponin levels and significant coronary lesions was 0.685 (95% CI: 0.65 - 0.72). In patients with or without renal failure, the areas under the ROC curve were 0.703 (95% CI: 0.66 - 0.74) and 0.608 (95% CI: 0.52 - 0.70), respectively. The best cutoff points to discriminate the presence of significant coronary lesion were: in the general population, 0.605 ng/dL (sensitivity, 63.4%; specificity, 67%); in patients without renal failure, 0.605 ng/dL (sensitivity, 62.7%; specificity, 71%); and in patients with chronic renal failure, 0.515 ng/dL (sensitivity, 80.6%; specificity, 42%). CONCLUSION: In patients with chest pain, sensitive troponin I showed a good correlation with significant coronary lesions when its level was greater than 0.605 ng/dL. In patients with chronic renal failure, a significant decrease in specificity was observed in the correlation of troponin levels and severe coronary lesions.
format Online
Article
Text
id pubmed-5831304
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Cardiologia - SBC
record_format MEDLINE/PubMed
spelling pubmed-58313042018-03-12 Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure Soeiro, Alexandre de Matos Gualandro, Danielle Menosi Bossa, Aline Siqueira Zullino, Cindel Nogueira Biselli, Bruno Soeiro, Maria Carolina Feres de Almeida Leal, Tatiana de Carvalho Andreucci Torres Serrano Jr., Carlos Vicente de Oliveira Junior, Mucio Tavares Arq Bras Cardiol Original Articles INTRODUCTION: Despite having higher sensitivity as compared to conventional troponins, sensitive troponins have lower specificity, mainly in patients with renal failure. OBJECTIVE: Study aimed at assessing the sensitive troponin I levels in patients with chest pain, and relating them to the existence of significant coronary lesions. METHODS: Retrospective, single-center, observational. This study included 991 patients divided into two groups: with (N = 681) and without (N = 310) significant coronary lesion. For posterior analysis, the patients were divided into two other groups: with (N = 184) and without (N = 807) chronic renal failure. The commercial ADVIA Centaur(®) TnI-Ultra assay (Siemens Healthcare Diagnostics) was used. The ROC curve analysis was performed to identify the sensitivity and specificity of the best cutoff point of troponin as a discriminator of the probability of significant coronary lesion. The associations were considered significant when p < 0.05. RESULTS: The median age was 63 years, and 52% of the patients were of the male sex. The area under the ROC curve between the troponin levels and significant coronary lesions was 0.685 (95% CI: 0.65 - 0.72). In patients with or without renal failure, the areas under the ROC curve were 0.703 (95% CI: 0.66 - 0.74) and 0.608 (95% CI: 0.52 - 0.70), respectively. The best cutoff points to discriminate the presence of significant coronary lesion were: in the general population, 0.605 ng/dL (sensitivity, 63.4%; specificity, 67%); in patients without renal failure, 0.605 ng/dL (sensitivity, 62.7%; specificity, 71%); and in patients with chronic renal failure, 0.515 ng/dL (sensitivity, 80.6%; specificity, 42%). CONCLUSION: In patients with chest pain, sensitive troponin I showed a good correlation with significant coronary lesions when its level was greater than 0.605 ng/dL. In patients with chronic renal failure, a significant decrease in specificity was observed in the correlation of troponin levels and severe coronary lesions. Sociedade Brasileira de Cardiologia - SBC 2018-01 /pmc/articles/PMC5831304/ /pubmed/29538525 http://dx.doi.org/10.5935/abc.20170182 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Soeiro, Alexandre de Matos
Gualandro, Danielle Menosi
Bossa, Aline Siqueira
Zullino, Cindel Nogueira
Biselli, Bruno
Soeiro, Maria Carolina Feres de Almeida
Leal, Tatiana de Carvalho Andreucci Torres
Serrano Jr., Carlos Vicente
de Oliveira Junior, Mucio Tavares
Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title_full Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title_fullStr Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title_full_unstemmed Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title_short Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure
title_sort sensitive troponin i assay in patients with chest pain - association with significant coronary lesions with or without renal failure
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831304/
https://www.ncbi.nlm.nih.gov/pubmed/29538525
http://dx.doi.org/10.5935/abc.20170182
work_keys_str_mv AT soeiroalexandredematos sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT gualandrodaniellemenosi sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT bossaalinesiqueira sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT zullinocindelnogueira sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT bisellibruno sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT soeiromariacarolinaferesdealmeida sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT lealtatianadecarvalhoandreuccitorres sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT serranojrcarlosvicente sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure
AT deoliveirajuniormuciotavares sensitivetroponiniassayinpatientswithchestpainassociationwithsignificantcoronarylesionswithorwithoutrenalfailure